Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers may be considered for post-ACS patients with systolic dysfunction, whereas statins should only be used for primary prevention of atherosclerosis or in patients with established concomitant atherosclerosis or diabetes mellitus [87, 88]. This evidence concerns the gene ACE and atherosclerosis.